Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Jan 24
Love0

Pigmented Basal Cell Carcinoma: An Argument for Sub-Classification

By Chuck Lin No Comments
INTRODUCTIONBasal cell carcinoma (BCC) is the most common skin malignancy among Caucasians, Asians, and Hispanics and the second most common amongst African-Americans.1 There are several recognized subtypes of BCC, including…
Read More
Jan 24
Love0

Differential RNA Transcriptome in Ustekinumab Responders vs Non-Responders

By Chuck Lin No Comments
CASEDespite numerous available psoriasis treatments, no "one size fits all"' regimen provides complete disease control without side effects, logistical obstacles, and/or expense. Despite increasingly efficacious drugs, only 20-25% of patients…
Read More
Jan 24
Love0

Online Health Information for Acne Keloidalis Nuchae has a Difficult Level of Readability

By Chuck Lin No Comments
INTRODUCTIONAcne keloidalis nuchae (AKN) is an inflammatory disorder primarily seen in individuals of color, characterized by acneiform and keloidal lesions on the occipital scalp/nuchal region.1 The global prevalence is 0.5%…
Read More
Jan 09
Love0

Molluscum Contagiosum Virus Evasion of Immune Surveillance: A Review

By Chuck Lin No Comments
INTRODUCTIONMolluscum contagiosum is a highly contagious, benign neoplastic, infectious dermatologic disease.1 It is commonly seen in children, sexually active young adults, and immunosuppressed patients.2,3 MC is a member of the…
Read More
Jan 01
Love0

Two-Step Skincare Regimen Addressing Aging in Three Unique Geographic Locations: A Prospective, Multi-Center, Open-Label Study

By Chuck Lin No Comments
INTRODUCTIONUltraviolet radiation (UVR), visible light (VL) radiation, and infrared radiation (IR) make up 6.8%, 38.9%, and 54.3% of the total solar radiation, respectively, and each plays a significant role in…
Read More
Jan 01
Love0

A Review of the Challenges and Nuances in Treating Rosacea in Asian Skin Types Using Cleansers and Moisturizers as Adjuncts

By Chuck Lin No Comments
INTRODUCTIONAn inflammatory skin disease associated with impaired skin barrier function, rosacea commonly involves the face.1-3 Symptoms of rosacea can be bothersome and include pain, stinging, burning, itching, and facial flushing.1-4…
Read More
Jan 01
Love0

FULL SUPPLEMENT: TAZAROTENE AND PSORIASIS: BIOLOGIC UNDERPINNINGS THAT IMPACT DISEASE CONTROL

By Chuck Lin No Comments
In this supplement:Oldie But Goodie Research over the past several years has elucidated the pathophysiology of psoriasis, yielding both new treatment options and enhanced knowledge of the mechanisms of action…
Read More
Jan 01
Love0

Supplement Individual Article: A Reappraisal of Fixed-Combination Halobetasol Propionate and Tazarotene for the Treatment of Psoriasis: Biological Underpinnings, Therapeutic Mechanisms, and Economic Considerations

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic inflammatory autoimmune condition that affects the skin and leads to a significantly reduced quality of life. Approximately 125 million people globally are estimated to be affected.1…
Read More
Jan 01
Love0

Supplement Individual Article: Oldie But Goodie

By Chuck Lin No Comments
Research over the past several years has elucidated the pathophysiology of psoriasis, yielding both new treatment options and enhanced knowledge of the mechanisms of action of existing treatments. As we…
Read More
Jan 01
Love0

FULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (NECOM ) 2: Skincare For Patients With Cancer in Scandinavia

By Chuck Lin No Comments
NECOM Skincare Algorithm for Patients With Cancer and SurvivorsCancer treatment-related cutaneous adverse events (cAEs) frequently occur, which can interfere with anticancer treatment outcomes and can severely impact quality of life…
Read More
Jan 01
Love0

Supplement Individual Article: NECOM Skincare Algorithm for Patients With Cancer and Survivors

By Chuck Lin No Comments
INTRODUCTIONThe 4 most commonly diagnosed cancers in the Nordic European countries in 2020 were lung, breast, prostate, and colorectal, accounting for almost half of all cancer diagnoses (175,925).1 The estimated…
Read More
Jan 01
Love0

Sixty Years of Benzoyl Peroxide Use in Dermatology

By Chuck Lin No Comments
INTRODUCTIONSynthesized in 1858 and produced commercially in the United States since 1927, benzoyl peroxide (BPO) is used extensively in industry and health care and is included on the World Health…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • JDD in the News: Topical Nonsteroidals for Chronic Hand Eczema May 30, 2026
  • Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study May 29, 2026
  • Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study May 28, 2026
  • Clinical Methodology to Evaluate the Efficacy of a Topical Cosmetic Eye Formulation on the Appearance of Dynamic Periorbital Lines May 27, 2026
  • Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ May 26, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference LVD        PDE       

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram